Related Experiment Videos

Novalgin in pain and fever

T Izhar1

  • 1Department of Paediatrics, Fatima Jinnah Medical College, Lahore.

Insights

Dipyrone (Novalgin) effectively and safely manages pain and fever in children. This study found good to satisfactory responses in over 92% of pediatric patients treated with the medication.

Area of Science:

  • Pediatric pharmacology
  • Pain management
  • Fever reduction

Background:

  • Fever and pain are common symptoms in children.
  • Effective and safe treatment options are crucial for pediatric care.
  • Dipyrone (Novalgin) is a widely used antipyretic and analgesic medication.

Purpose of the Study:

  • To evaluate the efficacy, tolerability, and safety of Dipyrone (Novalgin).
  • To assess its use in managing pain and fever in pediatric patients.

Main Methods:

  • An open, non-comparative study was conducted.
  • Participants included children aged 3 months to 12 years with fever (≥38.5°C) or pain.
  • The study was performed at Ganga Ram Hospital, Lahore.

Main Results:

  • Out of 93 children with fever, 66.7% showed a good response to Dipyrone.
  • An additional 25.8% experienced a satisfactory response.
  • Only 7.5% of patients had an unsatisfactory response to the treatment.

Conclusions:

  • Dipyrone (Novalgin) at a dosage of 10-15 mg/kg every 6-8 hours is effective for treating pain and fever in children.
  • The medication demonstrated a favorable safety and tolerability profile in the pediatric population.
Abstract

Related Concept Videos